Contraceptive Choices, Pregnancy Rates, and Outcomes in a Microbicide Trial

Por Sibeko, Sengeziwe, Baxter, Cheryl, Yende, Nonhlanhla, Karim, Quarraisha Abdool, Karim, Salim S Abdool
Publicado em 2011

Co-enrollment in multiple HIV prevention trials – Experiences from the CAPRISA 004 Tenofovir gel trial

Por Karim, Quarraisha Abdool, Kharsany, Ayesha B.M., Naidoo, Kasavan, Yende, Nonhlanhla, Gengiah, Tanuja, Omar, Zaheen, Arulappan, Natasha, Mlisana, Koleka P., Karim, Salim S. Abdool
Publicado em 2011

CD8(+) T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles

Por Koofhethile, Catherine K., Ndhlovu, Zaza M., Thobakgale-Tshabalala, Christina, Prado, Julia G., Ismail, Nasreen, Mncube, Zenele, Mkhize, Lungile, van der Stok, Mary, Yende, Nonhlanhla, Walker, Bruce D., Goulder, Philip J. R., Ndung'u, Thumbi
Publicado no J Virol (2016)

Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial

Por Karim, Quarraisha Abdool, Kharsany, Ayesha BM, Frohlich, Janet A, Baxter, Cheryl, Yende, Nonhlanhla, Mansoor, Leila E, Mlisana, Koleka P, Maarschalk, Silvia, Arulappan, Natasha, Grobler, Anneke, Sibeko, Sengeziwe, Omar, Zaheen, Gengiah, Tanuja N, Mlotshwa, Mukelisiwe, Samsunder, Natasha, Abdool Karim, Salim S
Publicado em 2011